

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.05905860 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.01861187 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.01861187 |
| 4 | rRNA modification (GO:0000154) | 3.95660489 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.88346941 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 3.88346941 |
| 7 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.50466609 |
| 8 | rRNA methylation (GO:0031167) | 3.46759466 |
| 9 | GDP-mannose metabolic process (GO:0019673) | 3.31727824 |
| 10 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.21467097 |
| 11 | cytidine metabolic process (GO:0046087) | 3.17070927 |
| 12 | cytidine catabolic process (GO:0006216) | 3.17070927 |
| 13 | cytidine deamination (GO:0009972) | 3.17070927 |
| 14 | response to thyroid hormone (GO:0097066) | 3.13332893 |
| 15 | autophagic vacuole fusion (GO:0000046) | 3.10578736 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 2.98858707 |
| 17 | respiratory chain complex IV assembly (GO:0008535) | 2.97471941 |
| 18 | cytochrome complex assembly (GO:0017004) | 2.90368587 |
| 19 | pseudouridine synthesis (GO:0001522) | 2.86931223 |
| 20 | regulation of mitochondrial translation (GO:0070129) | 2.80241936 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77538928 |
| 22 | blood coagulation, intrinsic pathway (GO:0007597) | 2.76157835 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.75962501 |
| 24 | protein carboxylation (GO:0018214) | 2.75962501 |
| 25 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.70093338 |
| 26 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66202478 |
| 27 | piRNA metabolic process (GO:0034587) | 2.58805766 |
| 28 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.58559112 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 2.58282277 |
| 30 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.57635439 |
| 31 | iron-sulfur cluster assembly (GO:0016226) | 2.54232461 |
| 32 | metallo-sulfur cluster assembly (GO:0031163) | 2.54232461 |
| 33 | DNA methylation involved in gamete generation (GO:0043046) | 2.54105630 |
| 34 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.53866116 |
| 35 | folic acid metabolic process (GO:0046655) | 2.52919522 |
| 36 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.51630771 |
| 37 | imidazole-containing compound metabolic process (GO:0052803) | 2.50249122 |
| 38 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.50056339 |
| 39 | tyrosine metabolic process (GO:0006570) | 2.46971486 |
| 40 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.46527169 |
| 41 | GPI anchor biosynthetic process (GO:0006506) | 2.45375908 |
| 42 | regulation of memory T cell differentiation (GO:0043380) | 2.44994200 |
| 43 | organelle membrane fusion (GO:0090174) | 2.43445282 |
| 44 | negative regulation of bone mineralization (GO:0030502) | 2.43019877 |
| 45 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.42596680 |
| 46 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.42416769 |
| 47 | S-adenosylmethionine metabolic process (GO:0046500) | 2.40417798 |
| 48 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.39136106 |
| 49 | C-terminal protein lipidation (GO:0006501) | 2.38568818 |
| 50 | protein complex biogenesis (GO:0070271) | 2.37046626 |
| 51 | methionine biosynthetic process (GO:0009086) | 2.35093283 |
| 52 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.34206786 |
| 53 | muscle organ morphogenesis (GO:0048644) | 2.33630223 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.33354156 |
| 55 | NAD biosynthetic process (GO:0009435) | 2.32581562 |
| 56 | positive regulation of defense response to virus by host (GO:0002230) | 2.31647100 |
| 57 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.30965352 |
| 58 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.30123399 |
| 59 | proteasome assembly (GO:0043248) | 2.29398759 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 2.29289188 |
| 61 | folic acid-containing compound metabolic process (GO:0006760) | 2.28352052 |
| 62 | L-methionine salvage (GO:0071267) | 2.26783084 |
| 63 | L-methionine biosynthetic process (GO:0071265) | 2.26783084 |
| 64 | amino acid salvage (GO:0043102) | 2.26783084 |
| 65 | positive regulation of granulocyte differentiation (GO:0030854) | 2.26530310 |
| 66 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.26522505 |
| 67 | xenobiotic catabolic process (GO:0042178) | 2.25782479 |
| 68 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.25755739 |
| 69 | ncRNA 3-end processing (GO:0043628) | 2.24693349 |
| 70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.22977204 |
| 71 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.22318870 |
| 72 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.22318870 |
| 73 | mannosylation (GO:0097502) | 2.22144508 |
| 74 | regulation of protein activation cascade (GO:2000257) | 2.19544404 |
| 75 | indole-containing compound catabolic process (GO:0042436) | 2.19313610 |
| 76 | indolalkylamine catabolic process (GO:0046218) | 2.19313610 |
| 77 | tryptophan catabolic process (GO:0006569) | 2.19313610 |
| 78 | urate metabolic process (GO:0046415) | 2.19267180 |
| 79 | proline metabolic process (GO:0006560) | 2.19196879 |
| 80 | cellular metabolic compound salvage (GO:0043094) | 2.18307660 |
| 81 | tetrahydrofolate metabolic process (GO:0046653) | 2.18048080 |
| 82 | regulation of translational fidelity (GO:0006450) | 2.16071780 |
| 83 | regulation of complement activation (GO:0030449) | 2.15395452 |
| 84 | oxaloacetate metabolic process (GO:0006107) | 2.14064399 |
| 85 | heme metabolic process (GO:0042168) | 2.13961334 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 2.13898625 |
| 87 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.13110436 |
| 88 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.13083077 |
| 89 | positive regulation of DNA recombination (GO:0045911) | 2.12559215 |
| 90 | short-chain fatty acid metabolic process (GO:0046459) | 2.12422297 |
| 91 | regulation of B cell apoptotic process (GO:0002902) | 2.12389135 |
| 92 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.11892830 |
| 93 | pyrimidine-containing compound salvage (GO:0008655) | 2.10947908 |
| 94 | pyrimidine nucleoside salvage (GO:0043097) | 2.10947908 |
| 95 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.10381041 |
| 96 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.10381041 |
| 97 | NADH dehydrogenase complex assembly (GO:0010257) | 2.10381041 |
| 98 | cytolysis (GO:0019835) | 2.09830202 |
| 99 | high-density lipoprotein particle remodeling (GO:0034375) | 2.09821712 |
| 100 | heme biosynthetic process (GO:0006783) | 2.09771803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.11563171 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.76732995 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.59067672 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.50510042 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.40287973 |
| 6 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36166535 |
| 7 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.35916005 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.35021253 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27587158 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.23155583 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.19071845 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18934047 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.11054625 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.05433273 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91014023 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.90027321 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87835431 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87626161 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.80339741 |
| 20 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.73926679 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73867418 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72797337 |
| 23 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.70066937 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69223638 |
| 25 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.65270158 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.64358648 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62973609 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62958928 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62482188 |
| 30 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.60246359 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60127920 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.55788737 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54038631 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.53486373 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52907966 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52720942 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52471369 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.51017616 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49367106 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46533263 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46447208 |
| 42 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.45877789 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44998465 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44402027 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44226944 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43307987 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42047922 |
| 48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40818643 |
| 49 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40637545 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.40279310 |
| 51 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38650464 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38089432 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37747233 |
| 54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35448128 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34089633 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33143433 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31848422 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.29109264 |
| 59 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.28272628 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28166303 |
| 61 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.27613021 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27231972 |
| 63 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27016353 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26546779 |
| 65 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.26270564 |
| 66 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.25931408 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25367449 |
| 68 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.24876844 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.24036637 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.23370698 |
| 71 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23343073 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22658694 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22107623 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21859363 |
| 75 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.21502835 |
| 76 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.20569760 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20353630 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16675540 |
| 79 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13174157 |
| 80 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.11820855 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11379231 |
| 82 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09972005 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08707623 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08606082 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08523226 |
| 86 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07663596 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07602067 |
| 88 | P300_27268052_Chip-Seq_Bcells_Human | 1.06579607 |
| 89 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.05693200 |
| 90 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05606935 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.04610554 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03860119 |
| 93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03074649 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03053495 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02804986 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 1.00904572 |
| 97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00716585 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00348786 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00119753 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98553649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.82479394 |
| 2 | MP0005451_abnormal_body_composition | 3.67923490 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.44471149 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.19687627 |
| 5 | MP0005464_abnormal_platelet_physiology | 2.87429726 |
| 6 | MP0000372_irregular_coat_pigmentation | 2.43386087 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.29071134 |
| 8 | MP0005360_urolithiasis | 2.27121875 |
| 9 | MP0001661_extended_life_span | 2.23789918 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.08771547 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.06973434 |
| 12 | MP0003195_calcinosis | 2.01009441 |
| 13 | MP0009840_abnormal_foam_cell | 1.95506214 |
| 14 | MP0005408_hypopigmentation | 1.94543492 |
| 15 | MP0002132_abnormal_respiratory_system | 1.90243242 |
| 16 | MP0000678_abnormal_parathyroid_gland | 1.89278200 |
| 17 | MP0005365_abnormal_bile_salt | 1.88899045 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 1.84295850 |
| 19 | MP0001545_abnormal_hematopoietic_system | 1.84295850 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.83566692 |
| 21 | MP0005671_abnormal_response_to | 1.79706407 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.74483062 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.69475916 |
| 24 | MP0005083_abnormal_biliary_tract | 1.65456526 |
| 25 | MP0009785_altered_susceptibility_to | 1.64298246 |
| 26 | MP0005171_absent_coat_pigmentation | 1.64059828 |
| 27 | MP0005332_abnormal_amino_acid | 1.60373903 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.57218323 |
| 29 | MP0003436_decreased_susceptibility_to | 1.55815071 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.51107419 |
| 31 | MP0001853_heart_inflammation | 1.48411084 |
| 32 | MP0005636_abnormal_mineral_homeostasis | 1.48365700 |
| 33 | MP0006082_CNS_inflammation | 1.43890378 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.43708745 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.42974057 |
| 36 | MP0005410_abnormal_fertilization | 1.36689472 |
| 37 | MP0008058_abnormal_DNA_repair | 1.36459799 |
| 38 | MP0005025_abnormal_response_to | 1.36378310 |
| 39 | MP0004947_skin_inflammation | 1.35503283 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.34717960 |
| 41 | MP0008469_abnormal_protein_level | 1.34597013 |
| 42 | MP0004381_abnormal_hair_follicle | 1.34107184 |
| 43 | MP0003186_abnormal_redox_activity | 1.33628629 |
| 44 | MP0001764_abnormal_homeostasis | 1.33592260 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.28797523 |
| 46 | MP0000681_abnormal_thyroid_gland | 1.28040734 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.26155386 |
| 48 | MP0002723_abnormal_immune_serum | 1.24017453 |
| 49 | MP0003786_premature_aging | 1.21408510 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.19841888 |
| 51 | MP0004147_increased_porphyrin_level | 1.18432993 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.18163891 |
| 53 | MP0009697_abnormal_copulation | 1.15983999 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.15174752 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.14583516 |
| 56 | MP0000609_abnormal_liver_physiology | 1.09927548 |
| 57 | MP0003045_fibrosis | 1.09825643 |
| 58 | MP0002419_abnormal_innate_immunity | 1.08519080 |
| 59 | MP0000858_altered_metastatic_potential | 1.08190599 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.07748664 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.07267108 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.07125866 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.06731162 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.06481378 |
| 65 | MP0009763_increased_sensitivity_to | 1.06470085 |
| 66 | MP0002398_abnormal_bone_marrow | 1.05606948 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.05186418 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.03989532 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.03161943 |
| 70 | MP0001819_abnormal_immune_cell | 1.03125703 |
| 71 | MP0003646_muscle_fatigue | 1.02764080 |
| 72 | MP0002452_abnormal_antigen_presenting | 1.02085862 |
| 73 | MP0002722_abnormal_immune_system | 1.01856313 |
| 74 | MP0001800_abnormal_humoral_immune | 1.01806563 |
| 75 | MP0005387_immune_system_phenotype | 1.00945656 |
| 76 | MP0001790_abnormal_immune_system | 1.00945656 |
| 77 | MP0000371_diluted_coat_color | 0.98400624 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.94738778 |
| 79 | MP0002429_abnormal_blood_cell | 0.94506356 |
| 80 | MP0002118_abnormal_lipid_homeostasis | 0.92322773 |
| 81 | MP0003075_altered_response_to | 0.91581951 |
| 82 | MP0003763_abnormal_thymus_physiology | 0.91532591 |
| 83 | MP0000716_abnormal_immune_system | 0.89409645 |
| 84 | MP0000685_abnormal_immune_system | 0.88735417 |
| 85 | MP0008995_early_reproductive_senescence | 0.86263488 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.84622957 |
| 87 | MP0000598_abnormal_liver_morphology | 0.84296477 |
| 88 | MP0003111_abnormal_nucleus_morphology | 0.83332172 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.82927627 |
| 90 | MP0005165_increased_susceptibility_to | 0.82761018 |
| 91 | MP0003718_maternal_effect | 0.81412353 |
| 92 | MP0005330_cardiomyopathy | 0.81245496 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.79579363 |
| 94 | MP0002405_respiratory_system_inflammati | 0.78506547 |
| 95 | MP0000639_abnormal_adrenal_gland | 0.77101767 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.76418522 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.75045408 |
| 98 | MP0008007_abnormal_cellular_replicative | 0.75009157 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.74972023 |
| 100 | MP0008004_abnormal_stomach_pH | 0.73601578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 4.58359990 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.84832305 |
| 3 | Purpura (HP:0000979) | 3.73083909 |
| 4 | Prolonged bleeding time (HP:0003010) | 3.70545208 |
| 5 | Renal Fanconi syndrome (HP:0001994) | 3.24559158 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 3.13097257 |
| 7 | Increased serum ferritin (HP:0003281) | 3.11736234 |
| 8 | Seborrheic dermatitis (HP:0001051) | 2.95931445 |
| 9 | Deep venous thrombosis (HP:0002625) | 2.83336139 |
| 10 | Abnormality of iron homeostasis (HP:0011031) | 2.79636812 |
| 11 | Prolonged neonatal jaundice (HP:0006579) | 2.75250556 |
| 12 | Hyperthyroidism (HP:0000836) | 2.72696769 |
| 13 | Menorrhagia (HP:0000132) | 2.72325985 |
| 14 | Aplastic anemia (HP:0001915) | 2.67645440 |
| 15 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.66918850 |
| 16 | Generalized aminoaciduria (HP:0002909) | 2.66876266 |
| 17 | Hepatocellular necrosis (HP:0001404) | 2.59770362 |
| 18 | Hemorrhage of the eye (HP:0011885) | 2.59561845 |
| 19 | Hepatic necrosis (HP:0002605) | 2.59475873 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.59118021 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.59118021 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 2.55236350 |
| 23 | Dysostosis multiplex (HP:0000943) | 2.54826545 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 2.54421860 |
| 25 | Reduced antithrombin III activity (HP:0001976) | 2.53040502 |
| 26 | Truncus arteriosus (HP:0001660) | 2.52501725 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 2.50713990 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.49339668 |
| 29 | Increased muscle lipid content (HP:0009058) | 2.49180767 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47035194 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47035194 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47035194 |
| 33 | Abnormality of lateral ventricle (HP:0030047) | 2.46882056 |
| 34 | Increased CSF lactate (HP:0002490) | 2.45282513 |
| 35 | Mitochondrial inheritance (HP:0001427) | 2.41850912 |
| 36 | Hypertensive crisis (HP:0100735) | 2.40537827 |
| 37 | Joint hemorrhage (HP:0005261) | 2.39522971 |
| 38 | Epistaxis (HP:0000421) | 2.39170821 |
| 39 | Ragged-red muscle fibers (HP:0003200) | 2.37822165 |
| 40 | Poikilocytosis (HP:0004447) | 2.34043403 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.29771160 |
| 42 | Lipid accumulation in hepatocytes (HP:0006561) | 2.27112526 |
| 43 | Male infertility (HP:0003251) | 2.26917105 |
| 44 | Abnormal gallbladder physiology (HP:0012438) | 2.26360531 |
| 45 | Cholecystitis (HP:0001082) | 2.26360531 |
| 46 | Increased serum lactate (HP:0002151) | 2.25838309 |
| 47 | Type I transferrin isoform profile (HP:0003642) | 2.20726911 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.19861966 |
| 49 | Reticulocytosis (HP:0001923) | 2.12267632 |
| 50 | Abnormal protein glycosylation (HP:0012346) | 2.11337712 |
| 51 | Abnormal glycosylation (HP:0012345) | 2.11337712 |
| 52 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.11337712 |
| 53 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.11337712 |
| 54 | Rough bone trabeculation (HP:0100670) | 2.11032328 |
| 55 | J-shaped sella turcica (HP:0002680) | 2.10693860 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10194151 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10194151 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10194151 |
| 59 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.09989757 |
| 60 | Cutaneous melanoma (HP:0012056) | 2.09879926 |
| 61 | Acute necrotizing encephalopathy (HP:0006965) | 2.08446680 |
| 62 | Testicular atrophy (HP:0000029) | 2.07655687 |
| 63 | Abnormality of the common coagulation pathway (HP:0010990) | 2.06233822 |
| 64 | Acute encephalopathy (HP:0006846) | 2.05203135 |
| 65 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.04971088 |
| 66 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99993508 |
| 67 | Acanthocytosis (HP:0001927) | 1.99298584 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 1.98916074 |
| 69 | Mucopolysacchariduria (HP:0008155) | 1.96363588 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96363588 |
| 71 | Gingival bleeding (HP:0000225) | 1.95288518 |
| 72 | Orthostatic hypotension (HP:0001278) | 1.94697214 |
| 73 | Pigmentary retinal degeneration (HP:0001146) | 1.94448652 |
| 74 | Abnormal pupillary function (HP:0007686) | 1.93851468 |
| 75 | Pustule (HP:0200039) | 1.92526323 |
| 76 | Obstructive lung disease (HP:0006536) | 1.90599123 |
| 77 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90599123 |
| 78 | Polycythemia (HP:0001901) | 1.90456735 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89020439 |
| 80 | Abnormal trabecular bone morphology (HP:0100671) | 1.87572899 |
| 81 | Esophageal neoplasm (HP:0100751) | 1.87324189 |
| 82 | Neoplasm of head and neck (HP:0012288) | 1.87324189 |
| 83 | Lactic acidosis (HP:0003128) | 1.86642554 |
| 84 | Complement deficiency (HP:0004431) | 1.86203876 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 1.85868037 |
| 86 | Atelectasis (HP:0100750) | 1.85635415 |
| 87 | Impaired platelet aggregation (HP:0003540) | 1.83682626 |
| 88 | Abnormal platelet function (HP:0011869) | 1.83682626 |
| 89 | Poor head control (HP:0002421) | 1.82415445 |
| 90 | Spastic paraparesis (HP:0002313) | 1.81651578 |
| 91 | Hypophosphatemic rickets (HP:0004912) | 1.79489109 |
| 92 | Acute hepatic failure (HP:0006554) | 1.78720154 |
| 93 | Opisthotonus (HP:0002179) | 1.75421290 |
| 94 | Joint swelling (HP:0001386) | 1.74062497 |
| 95 | Glomerulonephritis (HP:0000099) | 1.73888065 |
| 96 | Dysautonomia (HP:0002459) | 1.73514578 |
| 97 | Progressive microcephaly (HP:0000253) | 1.73058334 |
| 98 | Abnormality of macrophages (HP:0004311) | 1.72472861 |
| 99 | Short middle phalanx of the 5th finger (HP:0004220) | 1.72009995 |
| 100 | Premature graying of hair (HP:0002216) | 1.71334795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.74366971 |
| 2 | NME2 | 3.73863400 |
| 3 | ERN1 | 3.05470630 |
| 4 | IRAK3 | 2.91676077 |
| 5 | MST4 | 2.39850498 |
| 6 | TESK2 | 2.19135924 |
| 7 | TLK1 | 2.18041109 |
| 8 | MAPKAPK3 | 2.08619198 |
| 9 | EIF2AK1 | 2.05332356 |
| 10 | PIM2 | 2.04802765 |
| 11 | TBK1 | 2.00793366 |
| 12 | MAP2K6 | 1.86103202 |
| 13 | BMPR2 | 1.83877611 |
| 14 | STK16 | 1.83768320 |
| 15 | MAP4K1 | 1.81378828 |
| 16 | PDK2 | 1.76387490 |
| 17 | KDR | 1.65625174 |
| 18 | IKBKB | 1.64105183 |
| 19 | TXK | 1.63064600 |
| 20 | TRIB3 | 1.59404326 |
| 21 | MAP2K3 | 1.54642244 |
| 22 | TNK2 | 1.45215637 |
| 23 | RIPK4 | 1.40296979 |
| 24 | CCNB1 | 1.37888873 |
| 25 | VRK2 | 1.36524889 |
| 26 | MAP3K3 | 1.26590093 |
| 27 | ZAK | 1.24875335 |
| 28 | INSRR | 1.23031718 |
| 29 | ZAP70 | 1.22090600 |
| 30 | PRKD3 | 1.20568334 |
| 31 | TYK2 | 1.16577472 |
| 32 | MATK | 1.16314819 |
| 33 | ADRBK2 | 1.15884363 |
| 34 | GRK6 | 1.09020358 |
| 35 | WNK4 | 1.07357354 |
| 36 | GRK7 | 1.06505320 |
| 37 | ARAF | 1.06286208 |
| 38 | BMX | 1.04398468 |
| 39 | RAF1 | 1.04090329 |
| 40 | TAOK2 | 1.03505888 |
| 41 | TRPM7 | 1.01380169 |
| 42 | BCKDK | 0.99849474 |
| 43 | TRIM28 | 0.92333282 |
| 44 | MUSK | 0.91527462 |
| 45 | SYK | 0.90889737 |
| 46 | EIF2AK3 | 0.90601139 |
| 47 | KSR2 | 0.86597961 |
| 48 | CDK12 | 0.86075900 |
| 49 | MARK3 | 0.85655002 |
| 50 | MAP3K2 | 0.84535088 |
| 51 | MAP3K1 | 0.84300164 |
| 52 | CSF1R | 0.83930455 |
| 53 | ITK | 0.83674177 |
| 54 | MAP3K11 | 0.80563593 |
| 55 | MYLK | 0.77068970 |
| 56 | MAPK11 | 0.74159735 |
| 57 | SCYL2 | 0.72586339 |
| 58 | TEC | 0.71317980 |
| 59 | CLK1 | 0.71008821 |
| 60 | BTK | 0.70109157 |
| 61 | MAP3K14 | 0.67963797 |
| 62 | DAPK1 | 0.67868116 |
| 63 | ILK | 0.67690591 |
| 64 | PRKCI | 0.63441614 |
| 65 | GRK5 | 0.62666244 |
| 66 | PTK2B | 0.62479370 |
| 67 | PRKD2 | 0.59348691 |
| 68 | PDPK1 | 0.58744146 |
| 69 | FGFR4 | 0.58153004 |
| 70 | SIK3 | 0.57974526 |
| 71 | TGFBR2 | 0.57833615 |
| 72 | ABL2 | 0.57282021 |
| 73 | ICK | 0.56435811 |
| 74 | CDK7 | 0.55811677 |
| 75 | JAK3 | 0.54317240 |
| 76 | DAPK3 | 0.51855046 |
| 77 | PKN2 | 0.51780971 |
| 78 | MST1R | 0.51079822 |
| 79 | ATR | 0.50843526 |
| 80 | NME1 | 0.50828362 |
| 81 | PRKD1 | 0.48934687 |
| 82 | JAK2 | 0.48739203 |
| 83 | SIK1 | 0.48343220 |
| 84 | IRAK4 | 0.47188452 |
| 85 | PIM1 | 0.47092388 |
| 86 | PAK1 | 0.47043062 |
| 87 | BLK | 0.46189792 |
| 88 | TESK1 | 0.45334441 |
| 89 | MAPKAPK2 | 0.45324332 |
| 90 | CSNK1G3 | 0.44476696 |
| 91 | LYN | 0.44174227 |
| 92 | IKBKE | 0.43695577 |
| 93 | MAP3K13 | 0.43678458 |
| 94 | RPS6KA5 | 0.42076444 |
| 95 | MAPK3 | 0.41672152 |
| 96 | PDK1 | 0.41060258 |
| 97 | NTRK3 | 0.38838855 |
| 98 | MAP2K2 | 0.37016910 |
| 99 | DDR2 | 0.35390352 |
| 100 | JAK1 | 0.33735061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.17241907 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.73426047 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38567623 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.28041199 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.16972679 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.01948508 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98676888 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.91410758 |
| 9 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.84838271 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 1.80262475 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.76245638 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72735514 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63337158 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56874621 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.55907686 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.54199881 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52869822 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.51908007 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.51828659 |
| 20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.47426575 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.45265242 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44911284 |
| 23 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42359903 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39210584 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.39071216 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.39007435 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36635605 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.36134052 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.27562197 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.26895122 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24383782 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23492038 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21078677 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20285749 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15743922 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.15499355 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09052740 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07074837 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.06622177 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04746256 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03216114 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01060614 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99183733 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99124692 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98464102 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97823093 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.96094205 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95954020 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93632197 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.93460440 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92425794 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91800491 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89185614 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88450228 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85938355 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85632007 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85576655 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.83166262 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82514984 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81842989 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81104394 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.80148443 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79729864 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79686480 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79444394 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.73647556 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73621016 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72536895 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72068470 |
| 70 | Purine metabolism_Homo sapiens_hsa00230 | 0.71767972 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71707193 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69593653 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69569850 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67110022 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65163125 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64919834 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63594528 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63413124 |
| 79 | Ribosome_Homo sapiens_hsa03010 | 0.62268990 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61778474 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59005027 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58847932 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58401094 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57527237 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57259925 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.57025837 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55152238 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53385021 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.53341592 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52829912 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52771779 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52632286 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50187892 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.49862584 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48243321 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47709972 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46796565 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.46595201 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46405989 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45531865 |

